1636 материалов по теме, собраны автоматически из проверенных источников
Children with one of the deadliest forms of brain cancer may benefit from an additional course of radiation therapy after their disease returns, according to new research from the Icahn School of Medicine at Mount Sinai. The study, published in Practical Radiation Oncology, is the first to examine the experience of…
New research has found that more than 9 in 10 patients with bladder cancer were identified through a noninvasive urine test after urgent referral. The study, led by the University of Birmingham and Nonacus Ltd., involved 964 patients across seven NHS urology departments to examine the real-world significance of…
Югорские ученые провели важное исследование в области лечения рака яичников ГТРК Югория
Югорские ученые провели важное исследование в области лечения рака яичников ГТРК Югория
A new form of proton therapy—designed to deliver cancer-killing radiation therapy in less than a second, through fewer sessions, with potentially less risk of damaging side effects—is now being tested in a phase 1 clinical trial at the Abramson Cancer Center of the University of Pennsylvania. Known as FLASH proton…
Black women with endometrial cancer have significantly worse survival than white women, and much of that disparity comes from younger patients. An analysis of more than 13,000 women showed Black women aged 64 years and younger have a 159% greater risk for death than their white peers, compared with a 56% increased…
Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study markets.businessinsider.com
Blinded survival shifts timing in Can-Fite (NYSE: CANF) liver cancer study Stock Titan
People in a liver cancer study may be living longer than expected. Can-Fite may analyze the data sooner. Stock Titan
N-Power Medicine Secures $32M to Push Community Oncology Research citybiz
TNPET01 trial insights: PET imaging for predicting TNBC treatment response Oncology Central
Caregivers of Children with Cancer Engage in Culinary Medicine Classes and Coaching in New Drexel-Led Study Drexel
PMV Pharma’s Rezatapopt Achieves 44% Response Rate in TP53 Y220C Ovarian Cancer The Clinical Trial Vanguard
Cancer Clinical Trials Are Excluding the Patients They Are Meant to Help the-scientist.com
Curebound Adds Two Accomplished Leaders to Board to Advance Bold Cancer Research BioSpace